Preclinical in vitro evaluation of implantable materials: conventional approaches, new models and future directions
- PMID: 37576997
- PMCID: PMC10416115
- DOI: 10.3389/fbioe.2023.1193204
Preclinical in vitro evaluation of implantable materials: conventional approaches, new models and future directions
Abstract
Nowadays, implants and prostheses are widely used to repair damaged tissues or to treat different diseases, but their use is associated with the risk of infection, inflammation and finally rejection. To address these issues, new antimicrobial and anti-inflammatory materials are being developed. Aforementioned materials require their thorough preclinical testing before clinical applications can be envisaged. Although many researchers are currently working on new in vitro tissues for drug screening and tissue replacement, in vitro models for evaluation of new biomaterials are just emerging and are extremely rare. In this context, there is an increased need for advanced in vitro models, which would best recapitulate the in vivo environment, limiting animal experimentation and adapted to the multitude of these materials. Here, we overview currently available preclinical methods and models for biological in vitro evaluation of new biomaterials. We describe several biological tests used in biocompatibility assessment, which is a primordial step in new material's development, and discuss existing challenges in this field. In the second part, the emphasis is made on the development of new 3D models and approaches for preclinical evaluation of biomaterials. The third part focuses on the main parameters to consider to achieve the optimal conditions for evaluating biocompatibility; we also overview differences in regulations across different geographical regions and regulatory systems. Finally, we discuss future directions for the development of innovative biomaterial-related assays: in silico models, dynamic testing models, complex multicellular and multiple organ systems, as well as patient-specific personalized testing approaches.
Keywords: 3D models; biocompatibility; biomaterials; implants; organoids.
Copyright © 2023 Frisch, Clavier, Belhamdi, Vrana, Lavalle, Frisch, Heurtault and Gribova.
Conflict of interest statement
Authors AB, NV, and PL are employed by the company SPARTHA Medical. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures






Similar articles
-
Biocompatibility of polymer-based biomaterials and medical devices - regulations, in vitro screening and risk-management.Biomater Sci. 2018 Jul 24;6(8):2025-2053. doi: 10.1039/c8bm00518d. Biomater Sci. 2018. PMID: 29968869 Review.
-
Microengineered Organ-on-a-chip Platforms towards Personalized Medicine.Curr Pharm Des. 2018;24(45):5354-5366. doi: 10.2174/1381612825666190222143542. Curr Pharm Des. 2018. PMID: 30799783 Review.
-
Advanced Multi-Dimensional Cellular Models as Emerging Reality to Reproduce In Vitro the Human Body Complexity.Int J Mol Sci. 2021 Jan 26;22(3):1195. doi: 10.3390/ijms22031195. Int J Mol Sci. 2021. PMID: 33530487 Free PMC article. Review.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Stem cells based in vitro models: trends and prospects in biomaterials cytotoxicity studies.Biomed Mater. 2021 Mar 9;16(4):042003. doi: 10.1088/1748-605X/abe6d8. Biomed Mater. 2021. PMID: 33686970 Review.
Cited by
-
Preclinical Data Extrapolation to Clinical Reality: A Translational Approach.Curr Drug Discov Technol. 2025;22(3):e250424229318. doi: 10.2174/0115701638302778240417045451. Curr Drug Discov Technol. 2025. PMID: 38676496 Review.
-
Calcium Phosphates: A Key to Next-Generation In Vitro Bone Modeling.Adv Healthc Mater. 2024 Nov;13(29):e2401307. doi: 10.1002/adhm.202401307. Epub 2024 Aug 23. Adv Healthc Mater. 2024. PMID: 39175382 Free PMC article. Review.
-
Bifunctional mesoporous glasses for bone tissue engineering: Biological effects of doping with cerium and polyphenols in 2D and 3D in vitro models.Biomater Biosyst. 2024 May 31;14:100095. doi: 10.1016/j.bbiosy.2024.100095. eCollection 2024 Jun. Biomater Biosyst. 2024. PMID: 38912165 Free PMC article.
-
Towards Accurate Biocompatibility: Rethinking Cytotoxicity Evaluation for Biodegradable Magnesium Alloys in Biomedical Applications.J Funct Biomater. 2024 Dec 18;15(12):382. doi: 10.3390/jfb15120382. J Funct Biomater. 2024. PMID: 39728182 Free PMC article.
-
Metal Oxide Nanoparticles as Efficient Nanocarriers for Targeted Cancer Therapy: Addressing Chemotherapy-Induced Disabilities.Cancers (Basel). 2024 Dec 19;16(24):4234. doi: 10.3390/cancers16244234. Cancers (Basel). 2024. PMID: 39766133 Free PMC article. Review.
References
-
- Akiva A., Melke J., Ansari S., Liv N., van der Meijden R., van Erp M., et al. (2021). An organoid for woven bone. Adv. Funct. Mater. 31 (17), 2010524. 10.1002/adfm.202010524 - DOI
Publication types
LinkOut - more resources
Full Text Sources